[1] EpiConcept, Epidemiol Dept, 47 Rue Charenton, F-75012 Paris, France
[2] Natl Inst Publ Hlth, Ctr Epidemiol & Microbiol, Prague, Czech Republic
[3] French Natl Agcy Publ Hlth, Infect Dis Dept, St Maurice, France
[4] Hlth Protect Surveillance Ctr, Vaccine Preventable Dis Dept, Dublin, Ireland
[5] Norwegian Inst Publ Hlth, Dept Vaccine Preventable Dis, Oslo, Norway
[6] Publ Hlth Agcy Catalunya, Gen Sub Directorate Surveillance & Publ Hlth Emer, Barcelona, Spain
[7] Sub Directorate Hlth Promot & Prevent, Madrid, Spain
[8] Publ Hlth Inst Navarra IdiSNA, Pamplona, Spain
[9] CIBER Epidemiol & Salud Publ, Madrid, Spain
[10] Natl Serv Scotland, Hlth Protect Scotland, Glasgow, Lanark, Scotland
[11] Publ Hlth Agcy Sweden, Dept Microbiol, Solna, Sweden
[12] European Hosp George Pompidou, Natl Ctr Pneumococci, Paris, France
[13] Hosp San Juan Dios, Mol Microbiol Dept, Barcelona, Spain
[14] Univ Int Catalunya, Barcelona, Spain
[15] Meningococcus & Pneumococcus Reference Lab, Legionella, Scottish Haemophilus, Glasgow, Lanark, Scotland
[16] Karolinska Inst, Dept Microbiol Tumour & Cell Biol, Stockholm, Sweden
[17] Karolinska Univ Hosp, Dept Clin Microbiol, Stockholm, Sweden
[18] European Ctr Dis Prevent & Control, Off Chief Sci Unit, Stockholm, Sweden